Optimal Timing for Laparoscopic Cholecystectomy After Cholecystostomy in Acute Cholecystitis Tokyo II/III Setting
Launched by HOSPITAL ARNAU DE VILANOVA · Jun 19, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into the best timing for a surgery called laparoscopic cholecystectomy (a minimally invasive surgery to remove the gallbladder) after a procedure known as percutaneous drainage, which helps relieve symptoms in patients with acute cholecystitis (inflammation of the gallbladder). The goal is to find out when is the safest and most effective time to perform this surgery after drainage, especially for patients who have more severe cases of the condition.
To participate in this trial, you need to be over 18 years old and scheduled for gallbladder surgery. It's important that you agree to join the study and sign a consent form. If you have other health issues that could complicate your treatment or if your doctor feels you may not be able to follow the trial's requirements, you may not be eligible. Participants will be monitored closely to help researchers understand the best approach for surgery after drainage, which could lead to improved care for future patients with similar conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • patients over 18 years of age
- • patients candidates for cholecystectomy, in scheduled surgery
- • patients who accept participation and sign informed consent form
- Exclusion Criteria:
- • According to the principal investigator criteria, for reasons that make it impossible to correctly follow the treatment.
- • Presence of morbidity associated with the procedure that delays or makes treatment impossible.
About Hospital Arnau De Vilanova
Hospital Arnau de Vilanova is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a collaborative approach to research, the hospital serves as a vital center for clinical studies across various therapeutic areas. Leveraging state-of-the-art facilities and a multidisciplinary team of experts, Hospital Arnau de Vilanova aims to contribute to the development of new treatments and therapies that enhance the quality of life for patients both locally and globally. Its focus on ethical standards and rigorous scientific methodology ensures the integrity and reliability of its research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lleida, , Spain
Patients applied
Trial Officials
605387406 Vela Polanco, Dr
Principal Investigator
Hospital Arnau de Vilanova
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported